Literature DB >> 19660371

Two-year neurodevelopmental outcomes of infants undergoing neonatal cardiac surgery for interrupted aortic arch: a descriptive analysis.

Chloe A Joynt1, Charlene M T Robertson, Po-Yin Cheung, Alberto Nettel-Aguirre, Ari R Joffe, Reg S Sauve, Wayne S G Biggs, Norma J Leonard, David B Ross, Ivan M Rebeyka.   

Abstract

OBJECTIVE: This study determined neurodevelopmental outcomes of survivors of neonatal cardiac surgery for interrupted aortic arch through an interprovincial program and explored preoperative, intraoperative, and postoperative outcome predictors.
METHODS: Children who underwent neonatal cardiac surgery for interrupted aortic arch at 6 weeks old or younger between 1996 and 2006 had a multidisciplinary neurodevelopmental assessment at 18 to 24 months old (mental and psychomotor developmental indices as mean +/- SD and delay [score <70]). Survivor outcomes were compared by univariate and multivariate analyses and compared between children with and without chromosomal abnormality.
RESULTS: Outcomes were available for all 26 survivors (mortality, 3.7%). Mental and psychomotor developmental indices were 75.8 +/- 17.1 and 72.3 +/- 16.9, respectively, with significantly lower scores for children with chromosomal abnormalities, which accounted for 29% of the variance in developmental indices. For the remaining 17 children without chromosomal abnormalities, mental and psychomotor developmental indices were 82.7 +/- 14.5 and 79.1 +/- 14.3, respectively, with deep hypothermic circulatory arrest time and Apgar score at 5 minutes contributing 46% of the variance in mental developmental index.
CONCLUSIONS: The neurodevelopmental indices of children who have undergone neonatal cardiac surgery for interrupted aortic arch are below normative values; those of children with chromosomal abnormalities are even lower. For children without a chromosomal abnormality, longer deep hypothermic circulatory arrest times and low Apgar scores predict lower mental developmental indices at 18 to 24 months of age.

Entities:  

Mesh:

Year:  2009        PMID: 19660371     DOI: 10.1016/j.jtcvs.2009.03.016

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

Authors:  Eva Kapravelou; David Anderson; Gareth J Morgan
Journal:  Int J Angiol       Date:  2017-04-19

2.  Neurocognitive outcomes at kindergarten entry after surgical repair of total anomalous pulmonary venous connection in early infancy.

Authors:  Jonathan P Duff; Ari R Joffe; Shabnam Vatanpour; Diane M Moddemann; Charlene M T Robertson; Gwen Alton; Irina Dinu; David Ross; Ivan M Rebeyka
Journal:  Pediatr Cardiol       Date:  2014-09-11       Impact factor: 1.655

3.  Morbidity in children and adolescents after surgical correction of interrupted aortic arch.

Authors:  Michael L O'Byrne; Laura Mercer-Rosa; Huaqing Zhao; Xuemei Zhang; Wei Yang; Ronn E Tanel; Bradley S Marino; Amy Cassedy; Mark A Fogel; Jack Rychik; Stephen Paridon; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2013-09-15       Impact factor: 1.655

4.  The registry and follow-up of complex pediatric therapies program of Western Canada: a mechanism for service, audit, and research after life-saving therapies for young children.

Authors:  Charlene M T Robertson; Reg S Sauve; Ari R Joffe; Gwen Y Alton; Diane M Moddemann; Patricia M Blakley; Anne R Synnes; Irina A Dinu; Joyce R Harder; Reeni Soni; Jaya P Bodani; Ashok P Kakadekar; John D Dyck; Derek G Human; David B Ross; Ivan M Rebeyka
Journal:  Cardiol Res Pract       Date:  2011-05-08       Impact factor: 1.866

Review 5.  Developmental outcomes after early surgery for complex congenital heart disease: a systematic review and meta-analysis.

Authors:  Darlene Huisenga; Sacha La Bastide-Van Gemert; Andrew Van Bergen; Jane Sweeney; Mijna Hadders-Algra
Journal:  Dev Med Child Neurol       Date:  2020-03-09       Impact factor: 5.449

6.  Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome.

Authors:  Evelyn Ning Man Cheung; Susan R George; Danielle M Andrade; Eva W C Chow; Candice K Silversides; Anne S Bassett
Journal:  Genet Med       Date:  2013-06-13       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.